发明名称 Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents tocombat persistent infection
摘要 The invention provides methods and compositions for use in identifying inhibitors of biochemical pathways important for persistent infection, allowing the identification and/or design of improved therapeutics for treating persistent infections by pathogenic microbes. Particularly disclosed is the importance of the glyoxylate shunt to the persistent phase of various infectious agents, including Mycobacteria, such as M. tuberculosis, and the identification of preferred targets for drug development, including the enzymes isocitrate lyase (ICL) and malate synthase. Crystals and three-dimensional structures of M. tuberculosis ICL, without ligand and in complex with two inhibitors are also disclosed, for exemplary use in the design of inhibitors and therapeutic agents.
申请公布号 AU3391602(A) 申请公布日期 2002.04.29
申请号 AU20020033916 申请日期 2001.08.03
申请人 THE TEXAS A AND M UNIVERSITY SYSTEM;CORNELL UNIVERSITY;THE ROCKEFELLER UNIVERSITY;ALBERT EINSTEIN COLLEGE OF MEDICINE 发明人 JAMES C. SACCHETTINI;JOHN D. MCKINNEY;DAVID G. RUSSELL;WILLIAM R. JACOBS JR.;VIVEK SHARMA;SUJATA SHARMA;KERSTIN HENER ZU BENTRUP
分类号 C12Q1/02;C12Q1/04;C12Q1/527;G06F19/16 主分类号 C12Q1/02
代理机构 代理人
主权项
地址